What To Know About Multiple Sclerosis as a Pharmacist

Oct 22, 2021

Pharmacy Times spoke with neurologist Dr. Tirisham Gyang and pharmacist Dr. Margaret Hansen about multiple sclerosis, including diagnosis, treatment options, and the role of the pharmacist in patient care.

Pharmacy Times spoke with neurologist Dr. Tirisham Gyang and pharmacist Dr. Margaret Hansen about multiple sclerosis, including diagnosis, treatment options, and the role of the pharmacist in patient care.

Related Videos

Conference attendees watching a speaker | Image credit: kasto - stock.adobe.com

Biosimilars | Image credit: lexiconimages - stock.adobe.com

Medical care team | Image credit: Iryna - stock.adobe.com

Pharmacist helping patient | Image credit: Zamrznuti tonovi - stock.adobe.com

Healthcare technology | Image credit: ipopba | stock.adobe.com

Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com

Related Content

Analysis of Gut Microbiome Did Not Show Significant Differences Relating to Immune Checkpoint Inhibition Resistance

Pharmacy Focus: Student Edition - Creatives in Pharmacy

Larotrectinib Subgroup Analyses Demonstrate Long-Term Efficacy, Safety Profile in NTRK Gene Fusion Cancer

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Ribociclib Lowers Risk of Disease Recurrence by 25% for Early Breast Cancer

Five-Year Data Show Superiority of Upadacitinib to Adalimumab Treating Rheumatoid Arthritis

Analysis of Gut Microbiome Did Not Show Significant Differences Relating to Immune Checkpoint Inhibition Resistance

Pharmacy Focus: Student Edition - Creatives in Pharmacy

Larotrectinib Subgroup Analyses Demonstrate Long-Term Efficacy, Safety Profile in NTRK Gene Fusion Cancer

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Ribociclib Lowers Risk of Disease Recurrence by 25% for Early Breast Cancer

Five-Year Data Show Superiority of Upadacitinib to Adalimumab Treating Rheumatoid Arthritis

Analysis of Gut Microbiome Did Not Show Significant Differences Relating to Immune Checkpoint Inhibition Resistance

Pharmacy Focus: Student Edition - Creatives in Pharmacy

Larotrectinib Subgroup Analyses Demonstrate Long-Term Efficacy, Safety Profile in NTRK Gene Fusion Cancer

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Ribociclib Lowers Risk of Disease Recurrence by 25% for Early Breast Cancer

Five-Year Data Show Superiority of Upadacitinib to Adalimumab Treating Rheumatoid Arthritis

Related Content

Intestinal bacteria, Gut microbiome helps control intestinal digestion and the immune system, Probiotics are beneficial bacteria used to help the growth of healthy gut flora

Analysis of Gut Microbiome Did Not Show Significant Differences Relating to Immune Checkpoint Inhibition Resistance

Pharmacy Focus: Student Edition - Creatives in Pharmacy

Pharmacy Focus: Student Edition - Creatives in Pharmacy

3D Tumor Cancer Cells

Larotrectinib Subgroup Analyses Demonstrate Long-Term Efficacy, Safety Profile in NTRK Gene Fusion Cancer

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Woman Physician Talking With Her Patient | Image Credit: LStockStudio - stock.adobe.com

Ribociclib Lowers Risk of Disease Recurrence by 25% for Early Breast Cancer

Elderly woman applying moisturizing lotion cream on hand palm, easing aches. Senior old lady experiencing severe arthritis rheumatics pains, massaging, warming up arm. Close up, copy space, background | Image Credit: Evrymmnt - stock.adobe.com

Five-Year Data Show Superiority of Upadacitinib to Adalimumab Treating Rheumatoid Arthritis

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.